RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01
Symbol
RPID on Nasdaq
Shares outstanding
39,598,228
Price per share
$4.41
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
14,620,290
Total reported value
$42,504,363
% of total 13F portfolios
0%
Share change
-241,171
Value change
-$778,137
Number of holders
42
Price from insider filings
$4.41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Spignesi Robert G. Jr. 6.3% $9,133,033 2,647,256 SPIGNESI ROBERT G JR 28 Mar 2024
Endeavour Medtech Growth II LP 5.7% $6,545,587 2,257,099 Endeavour Medtech Growth II LP 31 Dec 2025

As of 31 Dec 2025, 42 institutional investors reported holding 14,620,290 shares of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID). This represents 37% of the company’s total 39,598,228 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Life Sciences Investors, LLC 21% 8,434,560 0% 1.9% $24,460,224
ABG-WTT Global Life Science Capital Partners GP Ltd 4.7% 1,848,296 0% 36% $5,360,058
VANGUARD GROUP INC 2.5% 978,781 +1.4% 0% $2,838,465
Advent International, L.P. 1.5% 577,777 0% 0.03% $1,675,553
Parkman Healthcare Partners LLC 0.9% 354,465 -61% 0.1% $1,027,949
Schonfeld Strategic Advisors LLC 0.89% 352,433 -45% 0.01% $1,022,055
GEODE CAPITAL MANAGEMENT, LLC 0.55% 217,568 +6.3% 0% $631,116
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.43% 172,235 +195% 0% $499,482
BlackRock, Inc. 0.4% 156,666 -68% 0% $454,332
CITADEL ADVISORS LLC 0.32% 126,539 0% $366,963
Evernest Financial Advisors, LLC 0.32% 125,000 -38% 0.1% $468,750
683 Capital Management, LLC 0.3% 120,773 0.03% $350,242
MILLENNIUM MANAGEMENT LLC 0.29% 116,502 0% $337,856
RENAISSANCE TECHNOLOGIES LLC 0.29% 115,627 +4.9% 0% $335,318
JANE STREET GROUP, LLC 0.27% 105,301 +176% 0% $305,372
SEI INVESTMENTS CO 0.24% 93,616 0% $271,486
STATE STREET CORP 0.23% 91,474 0% 0% $265,275
Informed Momentum Co LLC 0.19% 77,182 0.02% $223,828
MARSHALL WACE, LLP 0.16% 62,911 0% $182,443
ESSEX INVESTMENT MANAGEMENT CO LLC 0.16% 62,326 0% 0.03% $180,745
DIMENSIONAL FUND ADVISORS LP 0.14% 56,182 +0.97% 0% $162,481
GOLDMAN SACHS GROUP INC 0.14% 55,306 0% $160,387
NORTHERN TRUST CORP 0.1% 40,487 -15% 0% $117,412
Qube Research & Technologies Ltd 0.08% 33,099 0% $95,987
MORGAN STANLEY 0.08% 31,389 +53% 0% $91,028

Institutional Holders of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 14,620,290 $42,504,363 -$778,137 $2.90 42
2025 Q3 14,828,987 $49,529,221 -$1,092,903 $3.34 29
2025 Q2 15,145,610 $52,253,212 -$495,637 $3.45 29
2025 Q1 15,315,094 $40,431,707 +$9,172,017 $2.64 28
2024 Q4 11,949,084 $10,753,903 -$597,113 $0.90 18
2024 Q3 17,558,874 $15,627,447 -$775,836 $0.89 18
2024 Q2 18,509,095 $12,216,040 -$367,966 $0.66 18
2024 Q1 18,013,714 $17,474,138 -$839,869 $0.97 20
2023 Q4 20,091,717 $14,868,385 -$1,022,717 $0.74 24
2023 Q3 21,456,755 $23,172,706 -$417,040 $1.08 22
2023 Q2 21,872,837 $21,873,560 -$1,294,374 $1.00 22
2023 Q1 22,805,840 $29,875,332 -$3,621,510 $1.31 30
2022 Q4 24,500,193 $27,692,193 -$71,950 $1.13 40
2022 Q3 25,605,992 $82,661,264 -$10,626,216 $3.23 47
2022 Q2 26,054,592 $112,038,000 -$10,349,820 $4.30 47
2022 Q1 26,648,497 $180,967,834 +$33,474,300 $6.79 58
2021 Q4 21,436,197 $227,867,000 -$13,559,494 $10.64 55
2021 Q3 21,751,532 $401,371,000 +$401,371,000 $18.47 49